MedTrace Logo

Bringing South African Men Into HIV Counseling and Testing and Care

NCT03794245 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1806

Last updated 2023-07-07

No results posted yet for this study

Summary

This clinical trial seeks to determine if male-centered recruitment increases men's testing for HIV and whether or not individualized introduction to clinics increases male engagement in treatment for HIV. The study is being conducted in rural KwaZulu Natal.

Conditions

  • Human Immunodeficiency Virus

Interventions

BEHAVIORAL

Men-Centered HIV Testing

The intervention involves bringing mobile HIV testing to venues where men congregate, talking to them as a group about HIV testing, and then providing testing at that venue.

BEHAVIORAL

Linkage to Care for HIV+ Men

Men diagnosed with HIV are accompanied to the clinic and registered there with the help of a community health worker.

BEHAVIORAL

Clinic-based HIV Testing

Individuals present to a clinic and request HIV counseling and testing

BEHAVIORAL

Clinic Referral for HIV+ Men

Individuals diagnosed with HIV are referred to the nearest clinic for treatment of HIV

Sponsors & Collaborators

  • Human Sciences Research Council

    collaborator OTHER_GOV

  • Medical University of South Carolina

    collaborator OTHER

  • Charles University, Czech Republic

    collaborator OTHER

  • University of California, Los Angeles

    lead OTHER

Principal Investigators

  • THOMAS J COATES, PhD · University of California, Los Angeles

  • Heidi Van Rooyen, PhD · Human Sciences Research Council

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-07
Primary Completion
2021-12-01
Completion
2022-04-30

Countries

  • South Africa

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03794245 on ClinicalTrials.gov